Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11
about
Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11
@ast
Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11
@en
Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11
@nl
type
label
Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11
@ast
Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11
@en
Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11
@nl
prefLabel
Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11
@ast
Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11
@en
Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11
@nl
P2093
P2860
P1433
P1476
Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11
@en
P2093
Delphine Vandame
Helene Hirbec
Jacques Vignon
Lauriane Ulmann
Marisa Teigell
Monica Prieto-Cappellini
Olivera Nesic
Regino Perez-Polo
P2860
P304
P356
10.1371/JOURNAL.PONE.0081004
P407
P50
P577
2013-01-01T00:00:00Z